 Tunuguntla Kumar
Concepts (433)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Follicle Stimulating Hormone | 34 | 2024 | 244 | 6.100 |
Why?
| | Follicle Stimulating Hormone, beta Subunit | 23 | 2023 | 31 | 4.060 |
Why?
| | Testis | 15 | 2025 | 151 | 2.370 |
Why?
| | Luteinizing Hormone | 13 | 2022 | 185 | 2.070 |
Why?
| | Sertoli Cells | 10 | 2025 | 26 | 1.780 |
Why?
| | Spermatogenesis | 6 | 2025 | 67 | 1.720 |
Why?
| | Reproduction | 10 | 2019 | 204 | 1.630 |
Why?
| | Mice, Knockout | 38 | 2025 | 3008 | 1.600 |
Why?
| | Gonadotrophs | 3 | 2015 | 21 | 1.390 |
Why?
| | Integrases | 2 | 2025 | 120 | 1.320 |
Why?
| | Ovary | 17 | 2018 | 221 | 1.310 |
Why?
| | Pituitary Gland | 8 | 2020 | 148 | 1.240 |
Why?
| | Mice, Transgenic | 27 | 2025 | 2163 | 1.200 |
Why?
| | Mice | 79 | 2025 | 17757 | 1.080 |
Why?
| | Animals | 89 | 2025 | 36847 | 1.020 |
Why?
| | Follicle Stimulating Hormone, Human | 3 | 2023 | 12 | 0.980 |
Why?
| | Androgens | 5 | 2022 | 187 | 0.930 |
Why?
| | Ribonuclease III | 2 | 2015 | 40 | 0.930 |
Why?
| | DEAD-box RNA Helicases | 2 | 2015 | 76 | 0.900 |
Why?
| | Gene Knockout Techniques | 1 | 2025 | 117 | 0.890 |
Why?
| | Gonadotropins | 5 | 2022 | 40 | 0.890 |
Why?
| | Fertility | 8 | 2015 | 160 | 0.870 |
Why?
| | Receptors, FSH | 6 | 2018 | 9 | 0.780 |
Why?
| | Amino Acid Transport System y+ | 1 | 2022 | 9 | 0.770 |
Why?
| | Biology | 2 | 2019 | 88 | 0.700 |
Why?
| | Inhibins | 13 | 2008 | 44 | 0.680 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 465 | 0.660 |
Why?
| | Signal Transduction | 13 | 2018 | 5076 | 0.640 |
Why?
| | Leydig Cells | 6 | 2025 | 15 | 0.620 |
Why?
| | Laboratory Personnel | 1 | 2019 | 4 | 0.610 |
Why?
| | Genetics | 1 | 2019 | 23 | 0.600 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 5 | 2023 | 23 | 0.570 |
Why?
| | Luteinizing Hormone, beta Subunit | 3 | 2007 | 4 | 0.560 |
Why?
| | Oogenesis | 1 | 2017 | 20 | 0.540 |
Why?
| | Ovarian Follicle | 8 | 2019 | 71 | 0.530 |
Why?
| | Gene Expression Regulation | 11 | 2019 | 2605 | 0.500 |
Why?
| | Activin Receptors, Type II | 3 | 2005 | 12 | 0.500 |
Why?
| | Infertility | 3 | 2005 | 55 | 0.500 |
Why?
| | Recombinant Proteins | 4 | 2016 | 1350 | 0.500 |
Why?
| | Glycosylation | 4 | 2023 | 151 | 0.490 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 242 | 0.470 |
Why?
| | Models, Genetic | 1 | 2018 | 599 | 0.460 |
Why?
| | PAX7 Transcription Factor | 1 | 2014 | 13 | 0.450 |
Why?
| | Female | 54 | 2024 | 72796 | 0.450 |
Why?
| | Male | 49 | 2025 | 67311 | 0.440 |
Why?
| | RNA, Messenger | 14 | 2023 | 2831 | 0.440 |
Why?
| | Epididymis | 2 | 2012 | 12 | 0.430 |
Why?
| | Gonadotropin-Releasing Hormone | 6 | 2022 | 212 | 0.420 |
Why?
| | Spermatozoa | 2 | 2010 | 94 | 0.410 |
Why?
| | Gene Expression | 10 | 2020 | 1500 | 0.390 |
Why?
| | Steroids | 4 | 2018 | 167 | 0.390 |
Why?
| | Glycoproteins | 7 | 2004 | 342 | 0.390 |
Why?
| | Infertility, Female | 6 | 2003 | 108 | 0.390 |
Why?
| | Infertility, Male | 4 | 2001 | 61 | 0.380 |
Why?
| | Cyclin D3 | 1 | 2012 | 5 | 0.380 |
Why?
| | Granulosa Cells | 4 | 2019 | 33 | 0.380 |
Why?
| | Cyclin D2 | 1 | 2012 | 5 | 0.380 |
Why?
| | Cyclin D1 | 1 | 2012 | 68 | 0.370 |
Why?
| | Hypogonadism | 4 | 2014 | 88 | 0.370 |
Why?
| | Inhibin-beta Subunits | 3 | 2007 | 5 | 0.360 |
Why?
| | Testosterone | 8 | 2022 | 401 | 0.350 |
Why?
| | Chorionic Gonadotropin | 4 | 2007 | 80 | 0.350 |
Why?
| | Real-Time Polymerase Chain Reaction | 4 | 2016 | 346 | 0.350 |
Why?
| | Stem Cells | 3 | 2014 | 592 | 0.340 |
Why?
| | Molecular Imaging | 1 | 2010 | 53 | 0.340 |
Why?
| | Models, Animal | 3 | 2006 | 384 | 0.330 |
Why?
| | Plasmodium berghei | 4 | 2016 | 7 | 0.330 |
Why?
| | History, 20th Century | 3 | 2019 | 324 | 0.330 |
Why?
| | Biological Evolution | 1 | 2014 | 467 | 0.330 |
Why?
| | Embryonic Development | 1 | 2010 | 119 | 0.320 |
Why?
| | Oocytes | 3 | 2018 | 180 | 0.320 |
Why?
| | Anti-Mullerian Hormone | 4 | 2019 | 57 | 0.320 |
Why?
| | Aging | 4 | 2018 | 1864 | 0.310 |
Why?
| | Disease Models, Animal | 6 | 2012 | 4282 | 0.300 |
Why?
| | Gonadotropins, Pituitary | 2 | 2005 | 22 | 0.300 |
Why?
| | Osteoporosis | 3 | 2017 | 243 | 0.290 |
Why?
| | Pituitary Gland, Anterior | 4 | 1998 | 38 | 0.290 |
Why?
| | History, 21st Century | 2 | 2019 | 212 | 0.280 |
Why?
| | Ovulation | 3 | 2014 | 40 | 0.250 |
Why?
| | Receptors, Gonadotropin | 1 | 2005 | 1 | 0.250 |
Why?
| | Antimalarials | 3 | 2016 | 31 | 0.240 |
Why?
| | Testicular Neoplasms | 3 | 2008 | 110 | 0.240 |
Why?
| | Humans | 30 | 2024 | 136768 | 0.230 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 374 | 0.230 |
Why?
| | Transgenes | 4 | 2016 | 179 | 0.230 |
Why?
| | Sexual Behavior, Animal | 1 | 2005 | 57 | 0.230 |
Why?
| | Base Sequence | 9 | 2018 | 2179 | 0.230 |
Why?
| | Mutation | 9 | 2008 | 3946 | 0.220 |
Why?
| | MicroRNAs | 3 | 2017 | 692 | 0.220 |
Why?
| | Receptors, LHRH | 1 | 2003 | 14 | 0.220 |
Why?
| | Hormones | 1 | 2004 | 142 | 0.210 |
Why?
| | Cysteine | 2 | 2022 | 204 | 0.210 |
Why?
| | Receptors, Growth Factor | 2 | 2001 | 55 | 0.210 |
Why?
| | Freeze Drying | 1 | 2004 | 84 | 0.210 |
Why?
| | Ovarian Neoplasms | 4 | 2008 | 562 | 0.210 |
Why?
| | Mice, Inbred C57BL | 16 | 2013 | 5749 | 0.210 |
Why?
| | Blotting, Western | 2 | 2016 | 1225 | 0.200 |
Why?
| | Liver | 4 | 2018 | 1940 | 0.200 |
Why?
| | Adiposity | 2 | 2018 | 518 | 0.190 |
Why?
| | Cystine | 1 | 2022 | 18 | 0.190 |
Why?
| | Activins | 9 | 2020 | 28 | 0.190 |
Why?
| | Glutamates | 1 | 2022 | 59 | 0.190 |
Why?
| | Models, Biological | 4 | 2018 | 1773 | 0.190 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 179 | 0.190 |
Why?
| | Homeostasis | 2 | 2022 | 619 | 0.180 |
Why?
| | Genes, Dominant | 2 | 2013 | 95 | 0.180 |
Why?
| | Mice, Mutant Strains | 7 | 2013 | 298 | 0.180 |
Why?
| | gamma-Glutamyltransferase | 1 | 2000 | 43 | 0.170 |
Why?
| | Forkhead Box Protein L2 | 1 | 2020 | 3 | 0.170 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 452 | 0.170 |
Why?
| | Glutathione | 1 | 2022 | 356 | 0.170 |
Why?
| | Smad4 Protein | 1 | 2020 | 38 | 0.170 |
Why?
| | Promoter Regions, Genetic | 4 | 2018 | 1249 | 0.170 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2019 | 135 | 0.160 |
Why?
| | Biocompatible Materials | 1 | 2004 | 425 | 0.160 |
Why?
| | Receptors, Androgen | 3 | 2006 | 150 | 0.160 |
Why?
| | Genes, Lethal | 1 | 1999 | 30 | 0.160 |
Why?
| | Bone Morphogenetic Protein 15 | 2 | 2018 | 2 | 0.160 |
Why?
| | Growth Differentiation Factor 9 | 2 | 2018 | 4 | 0.160 |
Why?
| | Phenotype | 7 | 2007 | 3189 | 0.160 |
Why?
| | Genes, Tumor Suppressor | 2 | 1998 | 86 | 0.150 |
Why?
| | Spiro Compounds | 1 | 2018 | 14 | 0.150 |
Why?
| | Oxidants | 1 | 1999 | 111 | 0.150 |
Why?
| | Receptors, Steroid | 1 | 2019 | 50 | 0.150 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1998 | 18 | 0.150 |
Why?
| | Oligospermia | 2 | 2013 | 8 | 0.150 |
Why?
| | Bone and Bones | 3 | 2013 | 316 | 0.150 |
Why?
| | Esters | 1 | 2018 | 76 | 0.150 |
Why?
| | Neoplasms, Experimental | 2 | 1998 | 176 | 0.150 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2018 | 8 | 0.140 |
Why?
| | Texas | 1 | 2019 | 243 | 0.140 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 128 | 0.140 |
Why?
| | Benzene Derivatives | 2 | 2012 | 10 | 0.140 |
Why?
| | Placentation | 1 | 2018 | 45 | 0.140 |
Why?
| | Bone Development | 1 | 2018 | 54 | 0.140 |
Why?
| | Oligopeptides | 1 | 1999 | 271 | 0.140 |
Why?
| | Thermogenesis | 1 | 2017 | 44 | 0.130 |
Why?
| | Phosphorylation | 3 | 2019 | 1758 | 0.130 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 169 | 0.130 |
Why?
| | Gonads | 3 | 2007 | 23 | 0.130 |
Why?
| | Meiosis | 1 | 2017 | 81 | 0.130 |
Why?
| | Gene Targeting | 3 | 2007 | 81 | 0.130 |
Why?
| | Genital Neoplasms, Male | 1 | 1996 | 5 | 0.130 |
Why?
| | Aromatase | 3 | 2006 | 32 | 0.130 |
Why?
| | Time Factors | 4 | 2016 | 6808 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2016 | 17 | 0.130 |
Why?
| | Growth Substances | 4 | 1998 | 147 | 0.130 |
Why?
| | Osteoclasts | 2 | 2006 | 52 | 0.130 |
Why?
| | Pituitary Neoplasms | 1 | 1998 | 190 | 0.130 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 194 | 0.130 |
Why?
| | Cattle | 2 | 2015 | 981 | 0.130 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 209 | 0.120 |
Why?
| | Adenoma | 1 | 1998 | 230 | 0.120 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 145 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 254 | 0.120 |
Why?
| | Phagocytosis | 1 | 2017 | 379 | 0.120 |
Why?
| | Genital Neoplasms, Female | 1 | 1996 | 89 | 0.120 |
Why?
| | Autophagy | 1 | 2017 | 280 | 0.110 |
Why?
| | Wasting Syndrome | 3 | 2000 | 13 | 0.110 |
Why?
| | Cell Cycle | 3 | 2018 | 601 | 0.110 |
Why?
| | Metallothionein | 4 | 2003 | 25 | 0.110 |
Why?
| | Microscopy, Immunoelectron | 1 | 2014 | 44 | 0.110 |
Why?
| | Superovulation | 3 | 2006 | 8 | 0.110 |
Why?
| | Pituitary Hormones | 1 | 2013 | 16 | 0.110 |
Why?
| | Uterus | 3 | 2004 | 215 | 0.110 |
Why?
| | Triclosan | 2 | 2011 | 10 | 0.110 |
Why?
| | Molecular Sequence Data | 4 | 2006 | 2894 | 0.110 |
Why?
| | Osteocalcin | 1 | 2013 | 37 | 0.100 |
Why?
| | Thioctic Acid | 1 | 2013 | 11 | 0.100 |
Why?
| | Dihydrotestosterone | 1 | 1993 | 44 | 0.100 |
Why?
| | Malaria | 2 | 2011 | 63 | 0.100 |
Why?
| | Bone Resorption | 3 | 2013 | 86 | 0.100 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 324 | 0.100 |
Why?
| | Adipose Tissue | 1 | 2017 | 630 | 0.100 |
Why?
| | Malaria, Falciparum | 1 | 2012 | 27 | 0.100 |
Why?
| | Organ Specificity | 3 | 2012 | 304 | 0.100 |
Why?
| | Testicular Hormones | 2 | 2003 | 9 | 0.100 |
Why?
| | Pregnancy | 4 | 2018 | 6728 | 0.100 |
Why?
| | Urea | 1 | 2012 | 81 | 0.100 |
Why?
| | Protozoan Proteins | 2 | 2013 | 82 | 0.100 |
Why?
| | Apoptosis | 2 | 2017 | 2551 | 0.100 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2017 | 155 | 0.100 |
Why?
| | Rats | 4 | 2014 | 5639 | 0.090 |
Why?
| | Estradiol | 2 | 2008 | 518 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 688 | 0.090 |
Why?
| | Host-Parasite Interactions | 1 | 2013 | 114 | 0.090 |
Why?
| | Castration | 2 | 2003 | 14 | 0.090 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 111 | 0.090 |
Why?
| | Sex Factors | 3 | 2006 | 2060 | 0.090 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 220 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2014 | 1316 | 0.090 |
Why?
| | Epithelium | 1 | 2012 | 311 | 0.090 |
Why?
| | Anti-Infective Agents, Local | 1 | 2011 | 40 | 0.090 |
Why?
| | Pancreas | 1 | 2013 | 329 | 0.090 |
Why?
| | Osteoblasts | 2 | 2013 | 126 | 0.090 |
Why?
| | Sperm Motility | 1 | 2010 | 32 | 0.090 |
Why?
| | Ovariectomy | 3 | 2017 | 152 | 0.080 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 49 | 0.080 |
Why?
| | Amino Acid Sequence | 4 | 2013 | 2138 | 0.080 |
Why?
| | Seminal Vesicles | 2 | 2000 | 10 | 0.080 |
Why?
| | Radioimmunoassay | 2 | 2004 | 173 | 0.080 |
Why?
| | Embryo, Mammalian | 1 | 2010 | 232 | 0.080 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2006 | 316 | 0.080 |
Why?
| | Adipocytes | 3 | 2018 | 222 | 0.080 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 434 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 283 | 0.080 |
Why?
| | Homozygote | 3 | 1999 | 203 | 0.080 |
Why?
| | Orchiectomy | 3 | 1995 | 71 | 0.080 |
Why?
| | Pseudopregnancy | 1 | 2009 | 3 | 0.080 |
Why?
| | Infant | 1 | 2023 | 9398 | 0.080 |
Why?
| | Microinjections | 1 | 2009 | 86 | 0.080 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 26 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2009 | 1059 | 0.080 |
Why?
| | Hyperphagia | 1 | 2008 | 33 | 0.080 |
Why?
| | Plasmodium falciparum | 1 | 2008 | 30 | 0.080 |
Why?
| | Microscopy, Electron | 3 | 2013 | 432 | 0.070 |
Why?
| | Longevity | 2 | 2008 | 164 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2009 | 268 | 0.070 |
Why?
| | Kinetics | 2 | 2018 | 1664 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2122 | 0.070 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 2 | 2006 | 16 | 0.070 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 4 | 0.060 |
Why?
| | Spermatogonia | 1 | 2006 | 13 | 0.060 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 67 | 0.060 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 3405 | 0.060 |
Why?
| | 3' Flanking Region | 1 | 2006 | 7 | 0.060 |
Why?
| | Codon, Terminator | 1 | 2006 | 25 | 0.060 |
Why?
| | Copulation | 1 | 2005 | 5 | 0.060 |
Why?
| | Preoptic Area | 1 | 2005 | 8 | 0.060 |
Why?
| | Penis | 1 | 2005 | 36 | 0.060 |
Why?
| | Genes | 2 | 1995 | 230 | 0.060 |
Why?
| | Olfactory Pathways | 1 | 2005 | 36 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2006 | 316 | 0.060 |
Why?
| | Mice, Inbred ICR | 2 | 2003 | 119 | 0.060 |
Why?
| | Cyclic AMP | 2 | 2003 | 234 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1995 | 534 | 0.060 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 240 | 0.060 |
Why?
| | Gene Deletion | 4 | 2013 | 389 | 0.060 |
Why?
| | CHO Cells | 1 | 2004 | 161 | 0.060 |
Why?
| | Genetic Markers | 1 | 2005 | 344 | 0.060 |
Why?
| | Protein Subunits | 3 | 2014 | 239 | 0.060 |
Why?
| | Cricetinae | 1 | 2004 | 289 | 0.050 |
Why?
| | Thyrotropin | 1 | 2004 | 114 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2012 | 2475 | 0.050 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2006 | 327 | 0.050 |
Why?
| | Hypothyroidism | 1 | 2004 | 72 | 0.050 |
Why?
| | Biological Assay | 1 | 2004 | 123 | 0.050 |
Why?
| | Serum | 1 | 2004 | 59 | 0.050 |
Why?
| | Reference Values | 1 | 2005 | 816 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 200 | 0.050 |
Why?
| | DNA Damage | 1 | 2006 | 420 | 0.050 |
Why?
| | Peptides | 3 | 2000 | 980 | 0.050 |
Why?
| | Thecoma | 1 | 2003 | 2 | 0.050 |
Why?
| | Fibrin | 1 | 2004 | 81 | 0.050 |
Why?
| | Hypothalamus | 1 | 2003 | 153 | 0.050 |
Why?
| | Dimerization | 1 | 2003 | 198 | 0.050 |
Why?
| | Organ Size | 3 | 2013 | 477 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 975 | 0.050 |
Why?
| | Growth Inhibitors | 1 | 2001 | 43 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2017 | 4191 | 0.050 |
Why?
| | Phylogeny | 1 | 2006 | 903 | 0.050 |
Why?
| | Sperm Count | 1 | 2001 | 19 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 124 | 0.050 |
Why?
| | Protein Binding | 2 | 2018 | 2216 | 0.040 |
Why?
| | Protein Conformation | 1 | 2004 | 933 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1242 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2018 | 437 | 0.040 |
Why?
| | Cell Line | 5 | 2017 | 2838 | 0.040 |
Why?
| | Wound Healing | 1 | 2004 | 328 | 0.040 |
Why?
| | United States | 1 | 2018 | 14691 | 0.040 |
Why?
| | Sex Characteristics | 2 | 1998 | 759 | 0.040 |
Why?
| | Obesity | 2 | 2017 | 2982 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2004 | 362 | 0.040 |
Why?
| | Growth Hormone | 1 | 2000 | 101 | 0.040 |
Why?
| | Motor Activity | 1 | 2005 | 717 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2000 | 46 | 0.040 |
Why?
| | Growth Disorders | 1 | 2000 | 86 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 809 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2020 | 77 | 0.040 |
Why?
| | Follistatin | 4 | 2001 | 12 | 0.040 |
Why?
| | Acetylcysteine | 1 | 2000 | 145 | 0.040 |
Why?
| | tert-Butylhydroperoxide | 1 | 1999 | 10 | 0.040 |
Why?
| | Lethal Dose 50 | 1 | 1999 | 15 | 0.040 |
Why?
| | Mutagens | 1 | 1999 | 22 | 0.040 |
Why?
| | Fetal Death | 1 | 1999 | 55 | 0.040 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1455 | 0.040 |
Why?
| | Crosses, Genetic | 1 | 1999 | 137 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2018 | 36 | 0.040 |
Why?
| | Vibrissae | 1 | 1998 | 10 | 0.040 |
Why?
| | Cell Shape | 1 | 2018 | 57 | 0.040 |
Why?
| | Urinary Tract | 1 | 1999 | 51 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2018 | 43 | 0.040 |
Why?
| | Smad2 Protein | 1 | 2018 | 38 | 0.040 |
Why?
| | Hydrolysis | 1 | 2018 | 176 | 0.040 |
Why?
| | Curcumin | 1 | 2018 | 29 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2004 | 1733 | 0.040 |
Why?
| | Histone Code | 1 | 2018 | 34 | 0.040 |
Why?
| | Fluorescence | 1 | 2018 | 160 | 0.040 |
Why?
| | Embryonic and Fetal Development | 2 | 1995 | 97 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 2018 | 168 | 0.040 |
Why?
| | Snail Family Transcription Factors | 1 | 2018 | 17 | 0.040 |
Why?
| | Brain Stem | 1 | 1998 | 94 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1772 | 0.040 |
Why?
| | Acetylation | 1 | 2018 | 248 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2018 | 1396 | 0.030 |
Why?
| | Isoenzymes | 1 | 1998 | 304 | 0.030 |
Why?
| | Adipose Tissue, Beige | 1 | 2017 | 2 | 0.030 |
Why?
| | Uncoupling Protein 1 | 1 | 2017 | 16 | 0.030 |
Why?
| | DNA | 2 | 1995 | 1458 | 0.030 |
Why?
| | Gonadotropins, Equine | 1 | 1997 | 2 | 0.030 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2017 | 66 | 0.030 |
Why?
| | Adipose Tissue, White | 1 | 2017 | 41 | 0.030 |
Why?
| | Cell Death | 1 | 2018 | 372 | 0.030 |
Why?
| | Haploinsufficiency | 1 | 2017 | 56 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 327 | 0.030 |
Why?
| | Polycystic Ovary Syndrome | 1 | 1999 | 176 | 0.030 |
Why?
| | Tritium | 1 | 2016 | 76 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 366 | 0.030 |
Why?
| | Uridine | 1 | 2016 | 30 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 1998 | 346 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2016 | 90 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 507 | 0.030 |
Why?
| | Genes, Retinoblastoma | 1 | 1995 | 8 | 0.030 |
Why?
| | Growth | 1 | 1996 | 60 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2017 | 247 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 466 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1995 | 72 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2018 | 617 | 0.030 |
Why?
| | Genes, p53 | 1 | 1995 | 72 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2016 | 371 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 656 | 0.030 |
Why?
| | Blotting, Northern | 1 | 1995 | 200 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 657 | 0.030 |
Why?
| | Antibodies | 1 | 2017 | 411 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 385 | 0.030 |
Why?
| | Cell Differentiation | 4 | 2006 | 1982 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 1996 | 382 | 0.030 |
Why?
| | Introns | 1 | 1995 | 256 | 0.030 |
Why?
| | Exons | 1 | 1995 | 351 | 0.030 |
Why?
| | Hemorrhage | 1 | 1999 | 721 | 0.030 |
Why?
| | Adenosine | 1 | 2016 | 225 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 695 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1798 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 88 | 0.030 |
Why?
| | Body Weight | 2 | 2008 | 985 | 0.030 |
Why?
| | Immunoblotting | 1 | 1993 | 306 | 0.020 |
Why?
| | Desmocollins | 1 | 2012 | 2 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 514 | 0.020 |
Why?
| | Mice, Inbred C3H | 2 | 2006 | 269 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 306 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1089 | 0.020 |
Why?
| | Species Specificity | 1 | 1993 | 586 | 0.020 |
Why?
| | Drug Discovery | 1 | 2012 | 141 | 0.020 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2013 | 197 | 0.020 |
Why?
| | Survival Analysis | 2 | 2008 | 1321 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 190 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 556 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 375 | 0.020 |
Why?
| | Plasmodium | 1 | 2011 | 13 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 497 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2003 | 858 | 0.020 |
Why?
| | Rodentia | 1 | 2011 | 57 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1272 | 0.020 |
Why?
| | Flagella | 1 | 2010 | 20 | 0.020 |
Why?
| | Mitochondria | 1 | 2017 | 946 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 729 | 0.020 |
Why?
| | NF-kappa B | 2 | 2006 | 691 | 0.020 |
Why?
| | Transcription Factors | 2 | 2012 | 1718 | 0.020 |
Why?
| | Cell Division | 2 | 2003 | 796 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2012 | 500 | 0.020 |
Why?
| | Parasitemia | 1 | 2008 | 13 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 403 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2008 | 64 | 0.020 |
Why?
| | RNA | 1 | 1995 | 921 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 254 | 0.020 |
Why?
| | Corpus Luteum | 1 | 2007 | 20 | 0.020 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2007 | 18 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 357 | 0.020 |
Why?
| | Cachexia | 1 | 2008 | 71 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 364 | 0.020 |
Why?
| | Transcription Factor TFIID | 1 | 2007 | 21 | 0.020 |
Why?
| | Leptin | 1 | 2008 | 236 | 0.020 |
Why?
| | Disease Progression | 2 | 2008 | 2750 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2006 | 29 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2006 | 15 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 30 | 0.020 |
Why?
| | Protein Phosphatase 1 | 1 | 2006 | 33 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2006 | 4 | 0.020 |
Why?
| | Eating | 1 | 2008 | 379 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 171 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 283 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 766 | 0.010 |
Why?
| | Ascorbic Acid | 1 | 2006 | 176 | 0.010 |
Why?
| | Centrosome | 1 | 2004 | 71 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2006 | 810 | 0.010 |
Why?
| | Protein Kinases | 1 | 2006 | 319 | 0.010 |
Why?
| | Cell Polarity | 1 | 2004 | 141 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 466 | 0.010 |
Why?
| | Estrogens | 1 | 2006 | 367 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2007 | 769 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 43 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 3264 | 0.010 |
Why?
| | Transcription Factor AP-2 | 1 | 2003 | 82 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2008 | 919 | 0.010 |
Why?
| | Hypertrophy | 1 | 2003 | 133 | 0.010 |
Why?
| | Insulin | 1 | 2013 | 2406 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2006 | 528 | 0.010 |
Why?
| | Point Mutation | 1 | 2003 | 235 | 0.010 |
Why?
| | Progesterone | 1 | 2003 | 254 | 0.010 |
Why?
| | Enzymes | 1 | 2001 | 67 | 0.010 |
Why?
| | Multigene Family | 1 | 2001 | 198 | 0.010 |
Why?
| | Neoplasms | 1 | 1996 | 2644 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2000 | 20 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 941 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 1301 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 839 | 0.010 |
Why?
| | Trigeminal Nerve | 1 | 1998 | 27 | 0.010 |
Why?
| | Heterozygote | 1 | 1998 | 293 | 0.010 |
Why?
| | Liver Diseases | 1 | 2000 | 311 | 0.010 |
Why?
| | Follicular Cyst | 1 | 1996 | 1 | 0.010 |
Why?
| | Axons | 1 | 1998 | 198 | 0.010 |
Why?
| | Activin Receptors | 1 | 1995 | 3 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1501 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1998 | 664 | 0.010 |
Why?
| | Palate | 1 | 1995 | 38 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 78 | 0.010 |
Why?
| | Skull | 1 | 1995 | 139 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 1995 | 480 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2486 | 0.010 |
Why?
| | Middle Aged | 1 | 2013 | 33228 | 0.010 |
Why?
| | Adult | 1 | 2013 | 37630 | 0.010 |
Why?
| | Biomarkers | 1 | 2001 | 4144 | 0.010 |
Why?
| | Neurons | 1 | 1998 | 1587 | 0.000 |
Why?
|
|
Kumar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|